
Network News

Heidelberg, Germany, 19.12.2024 – RHEACELL today received approval from the European Medicines Agency (EMA) for its blinded, multi-centric Phase-3 trial (NCT06489028) evaluating allo-APZ2-CVU in patients with chronic venous ulcers (CVU). The pivotal trial will be conducted at more than 100 sites and is expected to enroll 250 patients, starting enrollment in Europe in Q1 2025. […]
read more
Common cough syrup ingredient shows promise in treating serious lung disease
EMBL scientists discover that an FDA-approved, over-the-counter cough syrup ingredient has potential to treat fibrotic lung disease. Summary A common over-the-counter ingredient in many cough syrups may have a greater purpose for people suffering from lung fibrosis that is related to any number of serious health conditions. Scientists from EMBL Heidelberg were part of a […]
read more
Antibody that Neutralizes Inhibitory Factors Involved in Nerve Regeneration Leads to Enhanced Motor Function after Acute Spinal Cord Injury
Antibodies can improve the rehabilitation of people with acute spinal cord injury. Researchers at 13 clinics in Germany, Switzerland, the Czech Republic and Spain have investigated this with promising results. For the first time, it was possible to identify patient groups that displayed a clinically relevant treatment effect. A follow-up study will start in December […]
read more
Colorectal cancer: role of obesity underestimated to date
Being overweight increases the risk of bowel cancer. The extent of this preventable risk factor has been significantly underestimated to date. Researchers at the German Cancer Research Center (DKFZ) have now reanalyzed a large pool of data and come to the conclusion that obesity is responsible for over 20 percent of bowel cancer cases. More […]
read more
Victoria Stodden to receive Humboldt Research Award
Victoria Stodden, statistician and associate professor at the Daniel J. Epstein Department of Industrial and Systems Engineering at the University of Southern California, has been selected to receive a prestigious Humboldt Research Award. Granted by the Alexander von Humboldt Foundation, the award is bestowed on internationally leading researchers in recognition of outstanding academic achievements. A […]
read more
Speaking the language of DNA
EMBL’s scientists have been instrumental in helping the world understand, decode, archive, and manipulate genomes at scale and across many branches of the evolutionary tree By Ewan Birney, Eileen Furlong, and Arnaud Krebs In 1978, British biochemist Frederick Sanger’s team released the genome sequence of ϕX174 – a virus that infects bacteria. The sequence – the […]
read more
A new EMBL microscope hits the road
Researchers developed a microscope made to travel – miniature in scale, fast in imaging samples, and giant in resolution. Microscopy allows us to see the unknown, solve mysteries, and advance knowledge. When EMBL scientists were looking to take the organisation’s world-class advanced microscopy from the lab to the field, as part of the Traversing European Coastlines […]
read more
New research group leader at the Max Planck Institute for Medical Research
From January 1, 2025, Roman Sarott and his research group “Chemically Induced Proximity” will develop small molecules with special function: they are designed to induce new interactions between proteins in order to reprogram cellular signaling pathways and thereby open up new therapeutic possibilities. “I am very much looking forward to my new role at the […]
read more
Shanghai Ranking of Academic Subjects: Outstanding Placings for Universität Heidelberg
Clinical medicine internationally in 17th position – medical technology ranks 16th worldwide With medical technology and clinical medicine, Heidelberg University is among the best representatives of the medical sciences worldwide. In the 2024 Global Ranking of Academic Subjects, medical technology ranks 16th internationally, which means second place in Germany. Clinical medicine moves up one place […]
read more